Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.

Stampanoni Bassi M, Iezzi E, Mori F, Simonelli I, Gilio L, Buttari F, Sica F, De Paolis N, Mandolesi G, Musella A, De Vito F, Dolcetti E, Bruno A, Furlan R, Finardi A, Marfia GA, Centonze D, Rizzo FR.

Neurorehabil Neural Repair. 2019 Aug 20:1545968319868713. doi: 10.1177/1545968319868713. [Epub ahead of print]

PMID:
31431121
2.

Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database.

Doneddu PE, Bianchi E, Cocito D, Manganelli F, Fazio R, Filosto M, Mazzeo A, Cosentino G, Cortese A, Jann S, Clerici AM, Antonini G, Siciliano G, Luigetti M, Marfia GA, Briani C, Lauria G, Rosso T, Cavaletti G, Carpo M, Benedetti L, Beghi E, Liberatore G, Santoro L, Peci E, Tronci S, Cotti Piccinelli S, Toscano A, Piccolo L, Verrengia EP, Leonardi L, Schirinzi E, Mataluni G, Ruiz M, Dacci P, Nobile-Orazio E; Italian CIDP Database Study Group.

Eur J Neurol. 2019 Jul 20. doi: 10.1111/ene.14044. [Epub ahead of print]

PMID:
31325350
3.

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.

Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulović J, Giovannoni G, Hartung HP, Arnold DL, Fisher E, Rudick R, Mi S, Chai Y, Li J, Zhang Y, Cheng W, Xu L, Zhu B, Green SM, Chang I, Deykin A, Sheikh SI; SYNERGY study investigators.

Lancet Neurol. 2019 Sep;18(9):845-856. doi: 10.1016/S1474-4422(19)30137-1. Epub 2019 Jul 5.

PMID:
31285147
4.

Current treatment practice of Guillain-Barré syndrome.

Verboon C, Doets AY, Galassi G, Davidson A, Waheed W, Péréon Y, Shahrizaila N, Kusunoki S, Lehmann HC, Harbo T, Monges S, Van den Bergh P, Willison HJ, Cornblath DR, Jacobs BC; IGOS Consortium.

Neurology. 2019 Jul 2;93(1):e59-e76. doi: 10.1212/WNL.0000000000007719. Epub 2019 Jun 7.

PMID:
31175208
5.

Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons.

Gentile A, De Vito F, Fresegna D, Rizzo FR, Bullitta S, Guadalupi L, Vanni V, Buttari F, Stampanoni Bassi M, Leuti A, Chiurchiù V, Marfia GA, Mandolesi G, Centonze D, Musella A.

Neuropathol Appl Neurobiol. 2019 May 24. doi: 10.1111/nan.12569. [Epub ahead of print]

PMID:
31125471
6.

Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis.

Stampanoni Bassi M, Gentile A, Iezzi E, Zagaglia S, Musella A, Simonelli I, Gilio L, Furlan R, Finardi A, Marfia GA, Guadalupi L, Bullitta S, Mandolesi G, Centonze D, Buttari F.

Front Neurol. 2019 Jan 29;10:30. doi: 10.3389/fneur.2019.00030. eCollection 2019.

7.

Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.

Massa R, Greco G, Testi M, Rastelli E, Terracciano C, Frezza E, Garibaldi M, Marfia GA, Locatelli F, Mercuri NB, Pompeo E, Antonini G, Andreani M.

J Neurol. 2019 Apr;266(4):982-989. doi: 10.1007/s00415-019-09225-z. Epub 2019 Feb 11.

PMID:
30741378
8.

Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis.

Nicoletti CG, Monteleone F, Marfia GA, Usiello A, Buttari F, Centonze D, Mori F.

Mult Scler. 2019 Feb 7:1352458519828294. doi: 10.1177/1352458519828294. [Epub ahead of print]

PMID:
30730244
9.

Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus.

Picconi F, Mataluni G, Ziccardi L, Parravano M, Di Renzo A, Ylli D, Pasqualetti P, Studer V, Chioma L, Marfia GA, Frontoni S.

J Diabetes Res. 2018 Oct 4;2018:9763507. doi: 10.1155/2018/9763507. eCollection 2018.

10.

Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database.

Doneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filosto M, Benedetti L, Mazzeo A, Marfia GA, Cortese A, Fierro B, Jann S, Beghi E, Clerici AM, Carpo M, Schenone A, Luigetti M, Lauria G, Antonini G, Rosso T, Siciliano G, Cavaletti G, Liberatore G, Santoro L, Peci E, Tronci S, Ruiz M, Cotti Piccinelli S, Toscano A, Mataluni G, Piccolo L, Cosentino G, Sabatelli M, Nobile-Orazio E; Italian CIDP Database study group.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):125-132. doi: 10.1136/jnnp-2018-318714. Epub 2018 Oct 8.

11.

Regional variation of Guillain-Barré syndrome.

Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RAC, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JAL, Mohammad QD, Monges S, Nobile Orazio E, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; IGOS Consortium.

Brain. 2018 Oct 1;141(10):2866-2877. doi: 10.1093/brain/awy232.

12.

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.

Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J; PARADIGMS Study Group.

N Engl J Med. 2018 Sep 13;379(11):1017-1027. doi: 10.1056/NEJMoa1800149.

13.

Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.

Stampanoni Bassi M, Iezzi E, Landi D, Monteleone F, Gilio L, Simonelli I, Musella A, Mandolesi G, De Vito F, Furlan R, Finardi A, Marfia GA, Centonze D, Buttari F.

J Neurol. 2018 Nov;265(11):2540-2547. doi: 10.1007/s00415-018-8994-5. Epub 2018 Aug 28.

PMID:
30167879
14.

Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study.

Mirabella M, Prosperini L, Lucchini M, Boffa L, Borriello G, Buscarinu MC, Centonze D, Cortese A, De Fino C, De Giglio L, Elia G, Fantozzi R, Ferraro E, Francia A, Galgani S, Gasperini C, Haggiag S, Landi D, Marfia GA, Millefiorini E, Monteleone F, Nociti V, Salvetti M, Sgarlata E, Pozzilli C.

CNS Drugs. 2018 Oct;32(10):963-970. doi: 10.1007/s40263-018-0543-3.

PMID:
30022464
15.

Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis.

Landi D, Ragonese P, Prosperini L, Nociti V, Haggiag S, Cortese A, Fantozzi R, Pontecorvo S, Ferraro E, Buscarinu MC, Mataluni G, Monteleone F, Salvetti M, Di Battista G, Francia A, Millefiorini E, Gasperini C, Mirabella M, Salemi G, Boffa L, Pozzilli C, Centonze D, Marfia GA.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1272-1278. doi: 10.1136/jnnp-2018-318468. Epub 2018 Jul 3.

PMID:
29970387
16.

Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study.

Prosperini L, Lucchini M, Haggiag S, Bellantonio P, Bianco A, Buscarinu MC, Buttari F, Centonze D, Cortese A, De Giglio L, Fantozzi R, Ferraro E, Fornasiero A, Francia A, Galgani S, Gasperini C, Marfia GA, Millefiorini E, Nociti V, Pontecorvo S, Pozzilli C, Ruggieri S, Salvetti M, Sgarlata E, Mirabella M.

Neurology. 2018 Jul 10;91(2):e153-e161. doi: 10.1212/WNL.0000000000005772. Epub 2018 Jun 6.

PMID:
29875218
17.

Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis.

Stampanoni Bassi M, Iezzi E, Marfia GA, Simonelli I, Musella A, Mandolesi G, Fresegna D, Pasqualetti P, Furlan R, Finardi A, Mataluni G, Landi D, Gilio L, Centonze D, Buttari F.

J Neuroinflammation. 2018 Apr 14;15(1):108. doi: 10.1186/s12974-018-1150-4.

18.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators.

Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23. Erratum in: Lancet. 2018 Nov 17;392(10160):2170.

PMID:
29576505
19.

The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis.

Farcomeni A, Cortese A, Sgarlata E, Alunni Fegatelli D, Marfia GA, Buttari F, Mirabella M, De Fino C, Prosperini L, Pozzilli C, Grasso MG, Iasevoli L, Di Battista G, Millefiorini E.

Neuroepidemiology. 2018;50(3-4):105-110. doi: 10.1159/000487005. Epub 2018 Mar 2.

PMID:
29502114
20.

Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea?

Izzi F, Placidi F, Liguori C, Lauretti B, Marfia GA, Pisani A, Mercuri NB, Rocchi C.

Sleep Med. 2018 Feb;42:68-72. doi: 10.1016/j.sleep.2017.09.029. Epub 2017 Oct 23.

PMID:
29458748
21.

Fingolimod reduces the clinical expression of active demyelinating lesions in MS.

Signoriello E, Landi D, Monteleone F, Saccà F, Nicoletti CG, Buttari F, Sica F, Marfia GA, Di Iorio G, Lus G, Centonze D.

Mult Scler Relat Disord. 2018 Feb;20:215-219. doi: 10.1016/j.msard.2018.02.002. Epub 2018 Feb 5.

PMID:
29433094
23.

Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach.

Stampanoni Bassi M, Gilio L, Buttari F, Maffei P, Marfia GA, Restivo DA, Centonze D, Iezzi E.

Front Neurosci. 2017 Dec 13;11:710. doi: 10.3389/fnins.2017.00710. eCollection 2017. Review.

24.

Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis.

Stampanoni Bassi M, Garofalo S, Marfia GA, Gilio L, Simonelli I, Finardi A, Furlan R, Sancesario GM, Di Giandomenico J, Storto M, Mori F, Centonze D, Iezzi E.

Front Mol Neurosci. 2017 Nov 21;10:390. doi: 10.3389/fnmol.2017.00390. eCollection 2017.

25.

Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain.

Monteleone F, Nicoletti CG, Stampanoni Bassi M, Iezzi E, Buttari F, Furlan R, Finardi A, Marfia GA, Centonze D, Mori F.

J Neuroimmunol. 2018 Jan 15;314:89-93. doi: 10.1016/j.jneuroim.2017.11.012. Epub 2017 Nov 20.

PMID:
29174194
26.

Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study.

Di Giuliano F, Albanese M, Picchi E, Mori F, Buttari F, Marfia GA, Garaci F, Mercuri NB, Floris R, Centonze D, Marziali S.

Radiol Med. 2018 Mar;123(3):202-208. doi: 10.1007/s11547-017-0829-4. Epub 2017 Nov 7.

PMID:
29116601
27.

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).

Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group.

J Neurol. 2017 Dec;264(12):2436-2449. doi: 10.1007/s00415-017-8642-5. Epub 2017 Oct 23.

28.

Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies.

Boso F, Ruggero S, Giannotta C, Benedetti L, Marfia GA, Ermani M, Campagnolo M, Salvalaggio A, Gallia F, De Michelis C, Visentin A, Bianco M, Ruiz M, Mataluni G, Nobile-Orazio E, Briani C.

Eur J Neurol. 2017 Nov;24(11):1334-1340. doi: 10.1111/ene.13387. Epub 2017 Aug 7.

PMID:
28782863
29.

Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability.

Studer V, Rocchi C, Motta C, Lauretti B, Perugini J, Brambilla L, Pareja-Gutierrez L, Camera G, Barbieri FR, Marfia GA, Centonze D, Rossi S.

Mult Scler J Exp Transl Clin. 2017 Apr 5;3(2):2055217317701317. doi: 10.1177/2055217317701317. eCollection 2017 Apr-Jun.

30.

Neurophysiology of synaptic functioning in multiple sclerosis.

Stampanoni Bassi M, Mori F, Buttari F, Marfia GA, Sancesario A, Centonze D, Iezzi E.

Clin Neurophysiol. 2017 Jul;128(7):1148-1157. doi: 10.1016/j.clinph.2017.04.006. Epub 2017 Apr 24. Review.

PMID:
28511127
31.

IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy.

Campagnolo M, Zambello R, Nobile-Orazio E, Benedetti L, Marfia GA, Riva N, Castellani F, Bianco M, Salvalaggio A, Garnero M, Ruiz M, Mataluni G, Fazio R, Ermani M, Briani C.

J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1094-1097. doi: 10.1136/jnnp-2017-315736. Epub 2017 May 13. No abstract available.

PMID:
28501820
32.

International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.

Jacobs BC, van den Berg B, Verboon C, Chavada G, Cornblath DR, Gorson KC, Harbo T, Hartung HP, Hughes RAC, Kusunoki S, van Doorn PA, Willison HJ; IGOS Consortium.

J Peripher Nerv Syst. 2017 Jun;22(2):68-76. doi: 10.1111/jns.12209.

PMID:
28406555
33.

TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis.

Buttari F, Zagaglia S, Marciano L, Albanese M, Landi D, Nicoletti CG, Mercuri NB, Silvestrini M, Provinciali L, Marfia GA, Mori F, Centonze D.

J Neuroimmunol. 2017 Apr 15;305:172-174. doi: 10.1016/j.jneuroim.2017.02.007. Epub 2017 Feb 8.

PMID:
28284340
34.

No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML.

Landi D, De Rossi N, Zagaglia S, Scarpazza C, Prosperini L, Albanese M, Buttari F, Mori F, Marfia GA, Sormani MP, Capra R, Centonze D; Italian PML study group.

Neurology. 2017 Mar 21;88(12):1144-1152. doi: 10.1212/WNL.0000000000003740. Epub 2017 Feb 22.

35.

Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities.

D'Amato C, Morganti R, Greco C, Di Gennaro F, Cacciotti L, Longo S, Mataluni G, Lauro D, Marfia GA, Spallone V.

Diab Vasc Dis Res. 2016 Nov;13(6):418-428. Epub 2016 Jun 22.

PMID:
27334483
36.

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.

Albanese M, Zagaglia S, Landi D, Boffa L, Nicoletti CG, Marciani MG, Mandolesi G, Marfia GA, Buttari F, Mori F, Centonze D.

J Neuroinflammation. 2016 Feb 10;13:36. doi: 10.1186/s12974-016-0502-1.

37.

RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.

Mori F, Nisticò R, Nicoletti CG, Zagaglia S, Mandolesi G, Piccinin S, Martino G, Finardi A, Rossini PM, Marfia GA, Furlan R, Centonze D.

Mult Scler. 2016 Oct;22(11):1405-1412. Epub 2016 Jan 5.

PMID:
26733422
38.

Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.

Mandolesi G, Gentile A, Musella A, Fresegna D, De Vito F, Bullitta S, Sepman H, Marfia GA, Centonze D.

Nat Rev Neurol. 2015 Dec;11(12):711-24. doi: 10.1038/nrneurol.2015.222. Epub 2015 Nov 20. Review.

PMID:
26585978
39.

Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?

Rocchi C, Albanese M, Placidi F, Romigi A, Lauretti B, Marfia GA, Liguori C, Marciani MG, Mercuri NB, Izzi F.

Sleep Med. 2015 Sep;16(9):1071-6. doi: 10.1016/j.sleep.2015.04.016. Epub 2015 May 28.

PMID:
26298781
40.

Heidenhain variant in two patients with inherited V210I Creutzfeldt-Jakob disease.

Imbriani P, Marfia GA, Marciani MG, Poleggi A, Pocchiari M, Puoti G, Caltagirone C, Pisani A.

Int J Neurosci. 2016;126(4):381-3. doi: 10.3109/00207454.2015.1047017. Epub 2015 Aug 13.

PMID:
26268049
41.

Brain MR diffusion tensor imaging in Kennedy's disease.

Garaci F, Toschi N, Lanzafame S, Marfia GA, Marziali S, Meschini A, Di Giuliano F, Simonetti G, Guerrisi M, Massa R, Floris R.

Neuroradiol J. 2015 Apr;28(2):126-32. doi: 10.1177/1971400915581740. Epub 2015 May 11.

42.

Hereditary spastic paraplegia: a novel mutation and expansion of the phenotype variability in SPG10.

Carosi L, Lo Giudice T, Di Lullo M, Lombardi F, Babalini C, Gaudiello F, Marfia GA, Massa R, Kawarai T, Orlacchio A.

J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):702-4. doi: 10.1136/jnnp-2014-308625. Epub 2014 Oct 28. No abstract available.

43.

Is autonomic nervous system involved in restless legs syndrome during wakefulness?

Izzi F, Placidi F, Romigi A, Lauretti B, Marfia GA, Mercuri NB, Marciani MG, Rocchi C.

Sleep Med. 2014 Nov;15(11):1392-7. doi: 10.1016/j.sleep.2014.06.022. Epub 2014 Aug 22.

PMID:
25266501
44.

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

Cocito D, Merola A, Peci E, Mazzeo A, Fazio R, Francia A, Valentino P, Liguori R, Filosto M, Siciliano G, Clerici AM, Lelli S, Marfia GA, Antonini G, Cecconi I, Nobile-Orazio E, Lopiano L; SCIg and Chronic Dysimmune Neuropathies Italian Network.

J Neurol. 2014 Nov;261(11):2159-64. doi: 10.1007/s00415-014-7444-2. Epub 2014 Aug 23.

45.

A novel association between nondipping and painful diabetic polyneuropathy.

D'Amato C, Morganti R, Di Gennaro F, Greco C, Marfia GA, Spallone V.

Diabetes Care. 2014 Sep;37(9):2640-2. doi: 10.2337/dc14-0528. Epub 2014 Jun 26.

PMID:
24969576
46.

The autonomic balance predicts cardiac responses after the first dose of fingolimod.

Rossi S, Rocchi C, Studer V, Motta C, Lauretti B, Germani G, Macchiarulo G, Marfia GA, Centonze D.

Mult Scler. 2015 Feb;21(2):206-16. doi: 10.1177/1352458514538885. Epub 2014 Jun 23.

PMID:
24957049
47.

Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis.

Rossi S, Motta C, Studer V, Rocchi C, Macchiarulo G, Barbieri F, Marfia G, Furlan R, Martino G, Mancino R, Centonze D.

Mult Scler. 2014 Dec;20(14):1841-50. doi: 10.1177/1352458514537365. Epub 2014 May 29.

PMID:
24876157
48.

Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes.

Ciccacci C, Morganti R, Di Fusco D, D'Amato C, Cacciotti L, Greco C, Rufini S, Novelli G, Sangiuolo F, Marfia GA, Borgiani P, Spallone V.

Acta Diabetol. 2014 Aug;51(4):663-71. doi: 10.1007/s00592-014-0582-2. Epub 2014 Mar 30.

PMID:
24682535
49.

Association of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis.

Testi M, Terracciano C, Guagnano A, Testa G, Marfia GA, Pompeo E, Andreani M, Massa R.

Autoimmune Dis. 2012;2012:541760. doi: 10.1155/2012/541760. Epub 2012 Oct 9.

50.

The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease.

Rocchi C, Pierantozzi M, Pisani V, Marfia GA, Di Giorgio A, Stanzione P, Bernardi G, Stefani A.

Eur Neurol. 2012;68(3):187-92. Epub 2012 Aug 28.

PMID:
22948481

Supplemental Content

Loading ...
Support Center